WFX-22696-67386
4 vaccinations
2 coded responses
32 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 730 / OK
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-16
Survey response — day 0, dose 1MedDRA: Injection site pain, Injection site reaction, Limb discomfort — Feeling: Fair · Site: PainFree text: Mild-moderate pain and heaviness in my arm at site of the injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-22
- 2020-12-25
- 2020-12-30
-
2021-01-06
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — day 0, dose 2Be unable to do your normal daily activities2 call case(s)
- 2021-01-08
- 2021-01-09
- 2021-01-13
- 2021-01-20
- 2021-01-29
- 2021-02-03
- 2021-02-12
- 2021-02-19
- 2021-04-07
-
2021-09-28
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-10-01
- 2021-10-02
- 2021-10-04
-
2021-10-07
Health check-in — day 7, dose 3Feeling: Good · Headache, Muscle or body aches, Diarrhea · Be unable to work or attend schoolAdult check-in
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-04
- 2021-11-09
-
2021-12-28
Survey response — 3 months, dose 3MedDRA: Cough, Discharge — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough, drainageMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-29
-
2021-12-30
Call successfulParticipant prefers to complete VAERS report online
- 2022-03-31
-
2022-05-10
Dose 4 — Pfizer-BioNTechCo-administered: Tetanus
- 2022-06-21
- 2022-08-09
- 2022-11-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
| 4 | 2022-05-10 | Pfizer-BioNTech | Tetanus |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-06 | priority 2/3 | |
| 2021-01-06 | priority 2/3 | |
| 2021-12-28 | Successful 2021-12-30 |
Participant prefers to complete VAERS report online |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Mild-moderate pain and heaviness in my arm at site of the injection
Release 10 — 3 months, dose 3
Symptoms: Cough, drainage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Discharge | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
| SRO | Limb discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release